Trials / Unknown
UnknownNCT02823054
One-lung Ventilation During Internal Thoracic Artery Grafting in Cardiac Surgery
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 208 (estimated)
- Sponsor
- Centre Hospitalier Universitaire, Amiens · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Coronary artery bypass grafting is a current cardiac surgery. Internal thoracic artery is usually taking to restore coronary revascularization, and its dissection can lead to accidental or voluntary pleural effusions. Respiratory complications are frequent, due to the drainage required. In this study, the investigators propose one-lung ventilation to facilitate artery grafting and surgical procedure. The investigators will include all adult patients with elective coronary artery bypass surgery (CABG) by internal thoracic artery, in a prospective, controlled, randomized and monocentric study. The main objective is to demonstrate that one-lung ventilation using EZ-Blocker can reduce pleural effusion defined by presence of drainage and/or pneumothorax on X-ray chest in the ICU.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | EZ-Blocker | the Blocker group, the EZ-Blocker will be set up after anesthesia induction and standard orotracheal intubation to allow lung exclusion during homolateral internal thoracic artery sampling, and thus a one-lung ventilation. This material will be removed at the end of surgical surgery. |
Timeline
- Start date
- 2017-01-04
- Primary completion
- 2020-01-01
- Completion
- 2020-01-01
- First posted
- 2016-07-06
- Last updated
- 2018-08-10
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02823054. Inclusion in this directory is not an endorsement.